Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation-Reference-Cited by-同舟云学术

Platelet recovery and transfusion needs after reduced intensity conditioning allogeneic peripheral blood stem cell transplantation

Published:2010-01 Issue:1 Volume:38 Page:55-60
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Prébet Thomas,Ladaique Patrick,Ferrando Martin,Chabannon Christian,Faucher Catherine,De Lavallade Hugues,El-Cheikh Jean,Furst Sabine,Vey Norbert,Stoppa Anne-Marie,Viens Patrice,Blaise Didier,Mohty Mohamad

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference20 articles.

1. Chronic graft versus host disease after allogeneic blood stem cell transplantation: long term results of a randomized study;Mohty;Blood,2002

2. Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer;Bregni;Blood,2002

3. Bleeding events and mortality in SCT patients: A retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD;Holler;Bone Marrow Transplant,2009

4. The major autopsy findings in adult patients after hematopoietic stem cell transplantation;Khayyata;Ann Transplant,2007

5. Non-myeloablative preparative regimens: experimental data and clinical practice;Storb;J Clin Oncol,1998

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the effect of pre-transplant thrombocytopenia and anemia on the engraftment and long-term survival in multiple myeloma patients;Transplant Immunology;2024-02

2. Lack of RBC transfusion independence by Day 30 following allogeneic hematopoietic stem cell transplant strongly predicts inferior survival and high non‐relapse mortality in acute myeloid leukemia patients;Transfusion;2024-01-15

3. Analysis of the Efficacy and Safety of Avatrombopag Combined With MSCs for the Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation;Frontiers in Immunology;2022-05-27

4. Transfusion burden following reduced intensity allogeneic hematopoietic cell transplantation: Impact of donor type;Transfusion;2021-04-26

5. Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplant;Transfusion;2020-08-03